GB9612990D0 - Compositions and methods for the treatment of chronic infections - Google Patents

Compositions and methods for the treatment of chronic infections

Info

Publication number
GB9612990D0
GB9612990D0 GBGB9612990.3A GB9612990A GB9612990D0 GB 9612990 D0 GB9612990 D0 GB 9612990D0 GB 9612990 A GB9612990 A GB 9612990A GB 9612990 D0 GB9612990 D0 GB 9612990D0
Authority
GB
United Kingdom
Prior art keywords
compositions
treatment
methods
chronic infections
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9612990.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Silence Therapeutics PLC
Original Assignee
Stanford Rook Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Rook Ltd filed Critical Stanford Rook Ltd
Priority to GBGB9612990.3A priority Critical patent/GB9612990D0/en
Publication of GB9612990D0 publication Critical patent/GB9612990D0/en
Priority to PCT/GB1997/001653 priority patent/WO1997048367A2/en
Priority to AU31030/97A priority patent/AU3103097A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB9612990.3A 1996-06-20 1996-06-20 Compositions and methods for the treatment of chronic infections Pending GB9612990D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9612990.3A GB9612990D0 (en) 1996-06-20 1996-06-20 Compositions and methods for the treatment of chronic infections
PCT/GB1997/001653 WO1997048367A2 (en) 1996-06-20 1997-06-18 Compositions for the treatment of chronic infections containing glucocorticoid and antiglucocorticoid
AU31030/97A AU3103097A (en) 1996-06-20 1997-06-18 Compositions and methods for the treatment of chronic infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612990.3A GB9612990D0 (en) 1996-06-20 1996-06-20 Compositions and methods for the treatment of chronic infections

Publications (1)

Publication Number Publication Date
GB9612990D0 true GB9612990D0 (en) 1996-08-21

Family

ID=10795646

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9612990.3A Pending GB9612990D0 (en) 1996-06-20 1996-06-20 Compositions and methods for the treatment of chronic infections

Country Status (3)

Country Link
AU (1) AU3103097A (en)
GB (1) GB9612990D0 (en)
WO (1) WO1997048367A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7736300A (en) 1999-09-30 2001-04-30 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
AU2002303427A1 (en) 2001-04-24 2002-11-05 East Carolina University Compositions and formulations with a non-glucocorticoid steroid and/or a ubiquinone and kit for treatment of respiratory and lung disease
US7405207B2 (en) 2002-06-17 2008-07-29 Epigenesis Pharmaceuticals, Inc. Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
US8084444B2 (en) * 2004-09-24 2011-12-27 Rxdino, Llc Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194728C (en) * 1987-04-16 2003-01-07 Hollis Eden Pharmaceuticals Pharmaceutical preparation suitable for the prophylaxis or therapy of a retroviral infection or a complication or consequence thereof.
US5077284A (en) * 1988-12-30 1991-12-31 Loria Roger M Use of dehydroepiandrosterone to improve immune response
DE69033541D1 (en) * 1989-09-25 2000-06-15 Univ Utah Res Found USE OF STEROID HORMONES IN PREPARATIONS FOR INDUCING T CELL LYMPHOKINE GENERATION
US5387583A (en) * 1993-04-20 1995-02-07 Loria; Roger M. Compositions containing corticosteroids or analogues thereof and corticosteroid buffering effective amounts of 5-androstene 3B, 17B or 5-androstene 3B, 7B, 17B triol or analogues thereof
AU2473695A (en) * 1994-05-09 1995-11-29 Johns Hopkins University, The Method of slowing the progression of hiv infection

Also Published As

Publication number Publication date
AU3103097A (en) 1998-01-07
WO1997048367A2 (en) 1997-12-24
WO1997048367A3 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
EP0939640A4 (en) Improvements in polymer compositions for chemotherapy and methods of treatment using the same
IL127446A (en) Compositions and methods for coating medical devices
HK1023371A1 (en) Compositions and methods for treating viral infections
GR3036364T3 (en) Compositions and methods for treating or preventing inflammatory diseases
HUP0103920A3 (en) Methods and compositions for the prevention and treatment of anemia
EP0717592A4 (en) Method and composition for the treatment of apathy-amotivation syndrome
AU2212299A (en) Compositions and methods for the treatment of tumor
AU2113295A (en) Novel compositions and methods for water treatment
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
GB9709360D0 (en) Methods for the treatment of herpes virus infections
ZA954984B (en) Compositions and methods for the treatment of tumors
PL332579A1 (en) Application of 1-hydroxy-2-pyridinones in treating dermatological infections
HK1018271A1 (en) Substituted benzylamines and their use for the treatment of depression
AU1556497A (en) Agents for the treatment and prevention of aids
AU3899893A (en) Compositions for the treatment of acute or chronic inflammation
HU9603116D0 (en) Compositions and treatment for multiple sclerosis
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL143212A0 (en) Compositions and methods for the treatment of tumor
IL119225A (en) Pharmaceutical compositions for the treatment of asthma in mammals
EP1139981A4 (en) Compositions and methods of using the same
GB9612990D0 (en) Compositions and methods for the treatment of chronic infections
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
AU5446798A (en) Compositions and methods for the treatment of gastrointestinal disorders
GB9726223D0 (en) The treatment of materials